MX365620B - Composiciones para el cuidado de la piel y metodos que comprenden agonistas selectivos del receptor de melanocortina 1. - Google Patents

Composiciones para el cuidado de la piel y metodos que comprenden agonistas selectivos del receptor de melanocortina 1.

Info

Publication number
MX365620B
MX365620B MX2015006342A MX2015006342A MX365620B MX 365620 B MX365620 B MX 365620B MX 2015006342 A MX2015006342 A MX 2015006342A MX 2015006342 A MX2015006342 A MX 2015006342A MX 365620 B MX365620 B MX 365620B
Authority
MX
Mexico
Prior art keywords
skin care
care compositions
methods
skin
melanocortin
Prior art date
Application number
MX2015006342A
Other languages
English (en)
Other versions
MX2015006342A (es
Inventor
A Abdel-Malek Zalfa
Koikov Leonid
J Knittel James
Original Assignee
Univ Cincinnati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cincinnati filed Critical Univ Cincinnati
Publication of MX2015006342A publication Critical patent/MX2015006342A/es
Publication of MX365620B publication Critical patent/MX365620B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a los tri- y tetra-péptidos cortos de acuerdo con la siguiente Fórmula I Ar (CH2) mX1-X2-CO-X3-X4-X5-(Trp) n-NX6R son agonistas, selectivos, potentes del receptor de melanocortina 1 (MC1R). Se proporcionan en la presente composiciones para el cuidado de la piel incluyendo los agonistas de péptido de la Fórmula I de MC1R y métodos para regular una afección de la piel de un mamífero que incluye aplicar a una superficie de tratamiento del cuerpo una cantidad segura y efectiva de una composición para el cuidado de la piel que incluye un péptido de la Fórmula I. Los péptidos, composiciones para el cuidado de la piel, y métodos para el cuidado de la piel descritos en la presente son útiles en regular una afección de la piel de un mamífero asociado con la exposición de la radiación ultravioleta (UV), incluyendo quemadura solar, sensibilidad de UV, fotoenvejecimiento y pigmentación de la piel, particullarmente en ausencia de exposición al sol.
MX2015006342A 2012-11-21 2013-11-20 Composiciones para el cuidado de la piel y metodos que comprenden agonistas selectivos del receptor de melanocortina 1. MX365620B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261729018P 2012-11-21 2012-11-21
PCT/US2013/071031 WO2014081845A2 (en) 2012-11-21 2013-11-20 Skin care compositions and methods comprising selective agonists of melanocortin 1 receptor

Publications (2)

Publication Number Publication Date
MX2015006342A MX2015006342A (es) 2016-02-25
MX365620B true MX365620B (es) 2019-06-07

Family

ID=50776668

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015006342A MX365620B (es) 2012-11-21 2013-11-20 Composiciones para el cuidado de la piel y metodos que comprenden agonistas selectivos del receptor de melanocortina 1.
MX2015006333A MX366171B (es) 2012-11-21 2013-11-20 Composiciones farmaceuticas y metodos terapeuticos de uso que comprenden agonistas selectivos del receptor de melanocortina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2015006333A MX366171B (es) 2012-11-21 2013-11-20 Composiciones farmaceuticas y metodos terapeuticos de uso que comprenden agonistas selectivos del receptor de melanocortina.

Country Status (7)

Country Link
US (3) US9434764B2 (es)
EP (2) EP2922565B1 (es)
AU (3) AU2013348044B2 (es)
CA (2) CA2892134C (es)
ES (2) ES2768423T3 (es)
MX (2) MX365620B (es)
WO (2) WO2014081846A2 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016187264A1 (en) * 2015-05-18 2016-11-24 The Arizona Board Of Regents On Behalf Of The University Of Arizona Enhanced melanoma cancer prevention by novel melanotropins
US10086035B2 (en) 2016-02-04 2018-10-02 ALASTIN Skincare, Inc. Compositions and methods for invasive and non-invasive procedural skincare
JP7039814B2 (ja) * 2016-10-04 2022-03-23 ディーエスエム アイピー アセッツ ビー．ブイ． メラノコルチン－１－受容体アゴニスト
CN111182914A (zh) 2017-08-03 2020-05-19 阿拉斯廷护肤公司 用于改善皮肤松弛和身体轮廓的组合物和方法
BR112020008175A2 (pt) * 2017-10-30 2020-10-20 Dsm Ip Assets B.V. compostos inovadores
JP7296642B2 (ja) * 2018-02-27 2023-06-23 リポトゥルー，エセ．エレ． 化粧料および医薬に使用するためのペプチドおよび組成物
WO2020028694A1 (en) 2018-08-02 2020-02-06 ALASTIN Skincare, Inc. Liposomal compositions and methods of use
BR112022025115A2 (pt) * 2020-06-10 2023-02-07 Mitsubishi Tanabe Pharma Corp Agente profilático ou terapêutico para fotodermatose
CN116925182A (zh) * 2022-04-02 2023-10-24 肽鼎生物科技（深圳）有限公司 多肽药物及凝胶制剂的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002536295A (ja) 1998-12-14 2002-10-29 パラチン テクノロジーズ， インク． 金属ペプチド組合せライブラリ及びその利用法
US6579968B1 (en) 1999-06-29 2003-06-17 Palatin Technologies, Inc. Compositions and methods for treatment of sexual dysfunction
CA2453515A1 (en) * 2001-07-11 2003-01-23 Palatin Technologies, Inc. Linear and cyclic melanocortin receptor-specific peptides
US7034004B2 (en) * 2002-05-07 2006-04-25 University Of Florida Peptides and methods for the control of obesity
WO2005048967A1 (en) 2003-11-24 2005-06-02 Clinuvel Pharmaceuticals Limited A method of inducing melanogenesis in humans with mc1r variant alleles
EP2368562B1 (en) 2004-10-08 2015-06-17 Clinuvel Pharmaceuticals Limited Compositions and methods for inducing melanogenesis in a subject
CA2702169A1 (en) * 2007-10-12 2009-04-16 Decode Genetics Ehf Sequence variants for inferring human pigmentation patterns
MX356295B (es) 2008-05-27 2018-05-22 Genzyme Corp Análogos de péptido de la hormona de estimulación de alfa-melanocito.
EA021897B1 (ru) * 2009-11-23 2015-09-30 Палатин Текнолоджиз, Инк. Циклические пептиды, специфичные к рецептору меланокортина-1

Also Published As

Publication number Publication date
CA2892134C (en) 2022-10-04
US20180066016A1 (en) 2018-03-08
CA2892144C (en) 2020-04-28
ES2738555T3 (es) 2020-01-23
US20150297667A1 (en) 2015-10-22
WO2014081845A3 (en) 2015-07-30
EP2925340A4 (en) 2017-01-04
US10301355B2 (en) 2019-05-28
WO2014081845A2 (en) 2014-05-30
WO2014081846A3 (en) 2015-11-19
EP2922565A2 (en) 2015-09-30
EP2922565A4 (en) 2016-06-15
US9434764B2 (en) 2016-09-06
MX366171B (es) 2019-07-01
ES2768423T3 (es) 2020-06-22
AU2013348044A1 (en) 2015-06-04
AU2018204153B2 (en) 2019-04-18
WO2014081846A2 (en) 2014-05-30
CA2892134A1 (en) 2014-05-30
AU2013348043B2 (en) 2017-11-02
AU2018204153A1 (en) 2018-06-28
US9834580B2 (en) 2017-12-05
EP2925340A2 (en) 2015-10-07
EP2922565B1 (en) 2019-11-13
EP2925340B1 (en) 2019-05-08
EP2925340B8 (en) 2019-07-24
US20150299251A1 (en) 2015-10-22
MX2015006342A (es) 2016-02-25
AU2013348043A1 (en) 2015-06-04
CA2892144A1 (en) 2014-05-30
AU2013348044B2 (en) 2018-03-15
MX2015006333A (es) 2016-01-20

Similar Documents

Publication Publication Date Title
MX2015006342A (es) Composiciones para el cuidado de la piel y metodos que comprenden agonistas selectivos del receptor de melanocortina 1.
BR112013004914A2 (pt) "composições de pele e métodos de uso das mesmas".
SV2011003948A (es) Uso de una composicion espumable esencialmente libre de ingredientes con actividad farmaceutica para el tratamiento de la piel humana
PE20151982A1 (es) Derivados de bencimidazolona como inhibidores del bromodominio
EP2528934A4 (en) AROMATIC-CATIONIC PEPTIDES AND USES THEREOF
IL219239A (en) Peptides for use in the treatment of skin, mucous membranes and / or hair and their use in cosmetic and pharmaceutical preparations
BR112015014454A2 (pt) composição de filtro solar e respectivos usos e métodos para proteger substrato queratinoso contra radiação ultravioleta e para absorvê-la
BR112013027893A2 (pt) produto de proteção solar e método de proteger as substâncias queratinosas da radiação uv
CL2010001624A1 (es) Uso de compuestos derivados de bisfenol diglicidil para tratar el cancer de prostata; compuestos derivados de bisfenol diglicidil eter; y composicion farmaceutica que compprende el compuesto.
MX347892B (es) Composiciones y metodos para el incremento del factor de proteccion solar mediante formulaciones cosmeticas en polvo de alta concentracion.
CU20130019A7 (es) Hormona foliculoestimulante humana recombinante, composición farmacéutica que la comprende
MX2015003074A (es) Formulaciones que comprenden idebenona, n-acetil-s-farnesil-l-cist eína y ergotioneína y usos de las mismas.
CL2011002634A1 (es) Disolucion acuosa sin alcohol etilico que comprende propanolol o una sal farmaceuticamente aceptable del mismo, un edulcorante tipo no azucarado y menos del 0,01 % (p/v) de un agente conservante; procedimiento de preparacion; uso de la disolucion en el tratamiento de hemangiomas.
AR081790A1 (es) Un metodo para mejorar el aspecto estetico de la piel, uso de tiliacora triandra en cosmeticos y composiciones, metodo para obtencion del extracto
WO2014151369A3 (en) Stabilized ezh2 peptides
BR112014007220A2 (pt) composição para cuidado pessoal e método para conferir volume ao cabelo
ES2862198T3 (es) Cosmético para aclarar la piel
EP3501532A3 (en) Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
WO2012116990A3 (en) Novel use
CO6660486A2 (es) Composición tópica famacéutica o cosmética útil para el tratamiento de enfermedades o condiciones que cursan con un déficit de la maduración de la envoltura córnea
AR110408A1 (es) Composición cosmética de maquillaje, base líquida y uso de una composición cosmética de maquillaje
NZ602380A (en) Peptides for vaccine against birch allergy
MX2015013883A (es) Composicion que comprende ciclodextrina como agente de proteccion de radiacion uv e ir.
AR082044A1 (es) Composicion humectante con spf 30
WO2019059511A3 (ko) 3,4-디-카페오일퀴닌산을 포함하는, 활성산소종, 자외선 또는 미세먼지에 대한 피부 보호용 화장료 조성물

Legal Events

Date Code Title Description
FG Grant or registration